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investigators of the Registry of the North Carolina Stroke Care Collaborative
Background-—Organized stroke care is associated with improved outcomes. Data are limited on differences in changes in the
quality of acute stroke care at The Joint Commission–certified Primary Stroke Centers (PSCs) versus non-PSCs over time.
Methods and Results-—We compared compliance with the Joint Commission’s 10 acute stroke care performance measures and
defect-free care in PSCs and non-PSCs participating in the Registry of the North Carolina Stroke Care Collaborative from January
2005 through February 2010. We included 29 654 cases presenting at 47 hospitals—10 PSCs, 8 preparing for certification, and
29 non-PSCs—representing 43% of North Carolina’s non–Veterans Affairs, acute care hospitals. Using a non-PSC referent, odds
ratios and 95% CIs were calculated using logistic regression and generalized estimating equations accounting for clustering of
cases within hospitals. Time trends were presented graphically using simple linear regression. Performance measure compliance
increased for all measures for all 3 groups in 2005–2010, with the exception of discharge on antithrombotics, which remained
consistently high. PSCs and hospitals preparing for certification had better compliance with all but 2 performance measures
compared with non-PSCs (each P<0.01). Defect-free care was delivered most consistently at hospitals preparing for certification
(52.8%), followed by PSCs (45.0%) and non-PSCs (21.9%). Between 2005 and 2010, PSCs and hospitals preparing for certification
had a higher average annual percent increase in the provision of defect-free care (P=0.01 and 0.04, respectively) compared with
non-PSCs.
Conclusions-—PSC certification is associated with an overall improvement in the quality of stroke care in North Carolina; however,
room for improvement remains. ( J Am Heart Assoc. 2014;3:e000423 doi: 10.1161/JAHA.113.000423)
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S troke is a leading cause of death and disability in theUnited States.1 Although effective therapies and evidence-
based processes that can improve stroke diagnosis and
treatment have been identified,2 gaps remain in their use.3 To
address these gaps, the American Heart Association/American
Stroke Association recommends establishing coordinated care
systems that integrate best practices in prevention, diagnosis,
treatment, and access.4 In 2004, The Joint Commission (JC)
launched the Primary Stroke Center (PSC) hospital certification
program that includes assessments of compliance with
consensus-based national standards, adherence to clinical
practice guidelines, and collection of standardized performance
measure (PM) data. Although there is considerable support for
the PSC concept—as of January 1, 2011, there were >800
PSCs in 49 states5—limited data exist comparing the quality of
acute stroke care at PSCs versus non-PSCs over time.5,6
The state-based registry of the North Carolina Stroke Care
Collaborative (NCSCC) collects data on PMs identical to those
required of PSC hospitals in a variety of hospitals, including those
that are neither capable of nor interested in becoming a PSC.We
compared compliance with the JC’s 10 PMs based on data
collected between January 2005 and February 2010 in PSC and
non-PSC hospitals, as well as in those preparing for certification.
Methods
The NCSCC is part of the Centers for Disease Control and
Prevention–funded Paul Coverdell National Acute Stroke
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Registry program. The prospective registry includes patients
18 years of age or older who present to North Carolina (NC)
hospital emergency departments (EDs) with signs or symp-
toms of stroke or transient ischemic attack. Hospitals eligible
for participation include all non–Veterans Affairs, NC acute
care hospitals with a dedicated ED, including critical-access
hospitals. All 110 eligible hospitals were invited to participate.
A detailed description of hospital characteristics has been
published.7
As previously described,7–9 trained hospital staff collect
data on demographics, initial presentation, quality-of-care
indicators, in-hospital outcomes, and discharge disposition
using a standardized, Internet-based data collection tool.
Whenever possible, data are collected concurrent with care. A
random sample of cases was reabstracted to assess data
quality (agreement 95.7%, j statistic .94). Patients directly
admitted to the hospital with a stroke are included; those with
a stroke during hospitalization are excluded.
Hospitals were grouped into 3 categories: hospitals
certified before registry enrollment (PSC), hospitals certified
after enrollment (preparing for certification), or hospitals that
remained uncertified by January 2011 (non-PSC).
Quality measures include the 10 items in the JC Stroke
Measure Set, used as part of the PSC certification process.
We also measured 2 additional, related measures of quality of
care: (1) received tissue plasminogen activator (tPA) within
3 hours of symptom onset and (2) received statin therapy as
indicated. We also measured “defect-free care,” a summary
variable reflecting whether a patient received all of the PMs
for which he or she was eligible.
Statistical Analysis
The v2 tests were used to compare baseline categorical
variables, and ANOVA was used for age in years. Proportions
were calculated to describe percent compliance with JC PMs
and defect-free care. The overall, unadjusted association
between PSC group and each PM and defect-free care was
evaluated using Pearson v2 statistics and 293 contingency
tables. Odds ratios (ORs) and 95% CIs for unadjusted models
were calculated using logistic regression, with non-PSCs as
the referent. Separate models were constructed for each of
the PMs and defect-free care. Models adjusted for patient-
level variables included age in years, sex, race (black, white,
and/or other), and stroke type (hemorrhagic, ischemic,
transient ischemic attack, or stroke not otherwise specified)
and used logistic regression. To investigate the effect of PSC
status while controlling for both patient-level factors and the
hospital size (<100, 100 to 349, or ≥350 beds), as well as
accounting for clustering of patients within hospitals, a
generalized estimating equations (GEE) approach was used.
Change in the percentage of cases in compliance with each
PM was averaged for each year between 2005 and 2010, and
absolute annual percent change was calculated and compared
using 2-sided F tests, with non-PSC hospitals as the reference
group. Trend lines in the plots of compliance with PMs over
time were created using simple linear regression and 3-month
time intervals.
All comparisons used an a priori .05 rejection level for the
null hypothesis. All statistical analyses were conducted using
SAS Version 9.1.10
This study was approved by the University of North
Carolina at Chapel Hill Institutional Review Board and
individual hospitals’ institutional review boards as required.
Results
Between January 1, 2005, and February 15, 2010, we enrolled
38 983 patients from 53 hospitals in NCSCC for whom we
had complete data (Figure 1). Cases at the 6 hospitals that
collected <6 months of data were excluded (n=291) as were
cases discharged as “no stroke” (n=2389). Cases entered
during the first 2 months of data collection were excluded
(n=1346) to minimize the “learning curve” effect, leaving 47
hospitals and 29 654 cases for analysis. During the study
period, there were 10 PSCs (n=14 885), 8 hospitals preparing
for certification (n=6974), and 29 non-PSCs (n=7795) in the
NCSCC. One third (n=17) of hospitals included in analyses
were located in nonmetropolitan counties, whereas nearly half
(n=23) were located in metropolitan areas with a population
of ≥250 000. Two hospitals were located in completely rural
areas (<2500 urban population). The median number of beds
for hospitals in the study population was 162 (interquartile
range 113 to 457) in 2012.
Compared with non-PSCs, PSCs and hospitals preparing
for certification tended to be larger (P<0.01), teaching
hospitals (P<0.01), and urban hospitals (P=0.03) (Table 1).
They were also more likely to have an intravenous (IV) tPA
protocol (P=0.04), an ED stroke protocol (P=0.02), a stroke
unit (P<0.01), and a neurosurgeon on staff (P<0.01). Cases at
PSCs tended to be younger (P<0.01), male (P<0.01), and
nonwhite (P<0.01) (Table 2).
PSCs and hospitals preparing for certification had higher
compliance with all but 2 PMs (smoking cessation counseling
and treatment of cases with atrial fibrillation with anticoag-
ulant therapy) compared with non-PSCs (P<0.01) (Table 3).
PSCs were the most likely to provide deep vein thrombosis
prophylaxis, antithrombotic agents, and IV tPA. Hospitals
preparing for certification were the most likely to measure
lipids during hospitalization, screen for dysphagia, provide
stroke education, and provide smoking cessation counseling.
Defect-free care was most common at hospitals preparing
for PSC certification (52.8%), followed by PSCs (45.0%) and
non-PSCs (21.9%).
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As shown in Table 4, PSC hospitals and those preparing for
certification had higher odds of complying with all measured
stroke performance indicators (including defect-free care)
with the exception of providing anticoagulants to patients with
atrial fibrillation (no statistical difference) and providing
smoking cessation counseling (PSCs had lower compliance
than non-PSCs). Adjustment for age, sex, race, and stroke
type altered ORs only modestly. Further adjustment for
hospital bed size and accounting for clustering of patients
within hospitals modestly attenuated some, but not all, ORs
but did widen CIs. With regard to hospitals preparing for
certification, CIs were widened to the point of nonsignificance
for discharge on antithrombotic, receipt of IV tPA, measure-
ment of lipids, and consideration for a rehabilitation plan.
There were substantial improvements in the quality of
acute stroke care from 2005 to 2010 (Table 5). Overall, PM
compliance increased for all measures and for all 3 hospital
groups (Figure 2), with the exception of discharge on
antithrombotic medication, which remained high throughout
the study period in all 3 groups. PSCs and hospitals in the
process of certification had consistently higher PM compli-
ance. Compared with non-PSCs, PSCs had a higher average
annual percent increase in smoking cessation counseling
(P<0.01), and those preparing for certification had the
greatest increases in the percent of patients for whom IV
tPA was considered (P<0.01) and in the percentage of eligible
cases who received IV tPA (P=0.04), those who had a lipid
profile measured during hospitalization (P<0.01), and those
who were discharged on a statin (P=0.04). PSCs and those
preparing for certification had a higher average annual
percent increase in the provision of defect-free care
(P=0.01 and 0.04, respectively) than non-PSCs. Compared
with hospitals preparing for certification, non-PSCs had a
higher average annual percent increase in the provision of
DVT prophylaxis (P=0.04), and compared with PSCs, non-
PSCs had a higher average annual percent increase in cases
administered IV tPA (P=0.01) and in cases discharged on a
statin (P=0.01).
Discussion
We found that the quality of stroke-related care improved in
hospitals participating in the NCSCC registry 2005 through
2010, but PSCs and hospitals preparing for certification had
higher compliance with most PMs. Moreover, PSCs and
hospitals preparing for certification had greater improvements
over time on a number of measures.
In unadjusted analyses, hospitals preparing for certification
had higher compliance than established PSCs for lipids
measured during hospitalization, dysphagia screening, stroke
education, smoking cessation counseling, consideration for a
rehabilitation plan, and overall defect-free care. These differ-
ences initially suggested support for the theory that when
preparing for certification, hospital personnel must devote a
great deal of time effort and commitment to improving stroke
care; however, thereafter, there may be a tendency toward
“complacency with past improvements”11 and a diminishment
in the urgency for continued quality improvement or a ceiling
effect with further improvements having relatively less impact.
However, after adjustment for patient-level factors and
hospital bed size and after accounting for the clustering of
patients within hospitals, these differences were removed,
suggesting PSCs continue to improve quality of stroke care,
even after certification.
Figure 1. North Carolina counties with a North Carolina Stroke Care Collaborative (NCSCC) hospital,
2005–2012.*
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Our finding that non-PSCs had a higher average annual
percent increase in cases administered IV tPA and in cases
discharged on a statin is likely due to the fact that baseline IV
tPA rates were much lower at baseline at non-PSCs (Table 3),
allowing for greater improvements in response to secular
trends. Rate of discharge on a statin was high for all 3 groups
(Table 3) but lowest for non-PSCs, again allowing for greater
improvement over time. PSC certification aims to improve the
process of stroke care delivery at many levels. Certification
requires hospitals to have stroke teams and stroke units and
to use standardized stroke care pathways to guide evaluation
and treatment of stroke.12 The quality of stroke care has
improved in recent years, both nationally13 and in NC.14 These
trends are reflected in our data, as even non-PSCs, which
include primarily small, rural, nonteaching hospitals, showed
improvements. A 2010 statewide survey of hospital-based
stroke services in NC reported that the introduction of the
JC’s PSC certification process occurred concurrent with
significant improvements in a number of important organiza-
tional features in NC hospitals, including the use of stroke
care maps, IV tPA protocols, stroke teams, prewritten stroke
orders, and diagnostic tests that were not seen in the period
preceding the PSC certification program.14 Organizational and
procedural changes such as these are likely important
drivers of improved compliance with stroke treatment
recommendations.15
Differences in acute stroke care quality at PSCs compared
with non-PSCs have been reported. For example, one study
found that patients admitted to PSCs were more likely to
receive IV tPA.6 Another reported that in New York State,
patients cared for at PSCs had shorter median door-to-
physician times, a higher probability of appropriate IV tPA
administration, and a higher probability of stroke unit
admission.16 Shorter time to computed tomography scan at
PSCs compared with non-PSCs has been reported in a
previous NCSCC study.9 PSC-like programs in other countries
Table 1. Characteristics of Hospitals Participating in the North Carolina Stroke Care Collaborative, 2005–2010, by PSC
Certification Status
PSC Preparing for Certification Non-PSC v2 P Value
N 10 8 29
Community type, %
Rural 0 0 3.5 0.73
Small town 0 0 20.7 0.12
Micropolitan 10.0 50.0 37.9 0.16
Urban/metropolitan 90.0 50.0 37.9 0.03
Bed size, %
<100 0 25.0 31.0 0.13
100 to 249 20.0 25.0 58.6 0.05
250 to 499 0 37.5 10.3 0.05
500+ 80.0 12.5 0 <0.01
Teaching hospital, % 90.0 37.5 13.8 0.01
Community access hospital, % 0 0 24.1 0.08
Process measures, %
Acute stroke team 80.0 50.0 24.1 0.07
tPA protocol 100 87.5 51.7 0.04
Emergency department protocol 100 50.0 44.8 0.02
Protocols revised weekly 90.0 37.5 34.5 0.02
Stroke unit 80.0 62.5 20.7 <0.01
Stroke unit general ward 80.0 62.5 13.8 <0.01
Neurosurgery on staff 90.0 62.5 24.1 <0.01
Neurosurgery 24/7 in 2 hours 90.0 37.5 13.8 <0.01
Written plan for EMS transport 80.0 50.0 41.4 0.16
EMS notification activate protocol 90.0 62.5 20.7 <0.01
PSC indicates Primary Stroke Center; tPA, tissue plasminogen activator; EMS, emergency medical services.
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have reported similar improvements in acute stroke care.
In Japan, investigators reported an increase from 1.2% to 2.8%
in IV tPA administration among eligible patients and a
significant decrease in response time following PSC estab-
lishment.17
Studies of the effect of PSC certification on mortality and
discharge destination suggest a survival benefit. Stroke
mortality rates at PSCs were lower than non-PSCs in New
York State (ie, 30-day mortality, 10.1% versus 12.5%;
P<0.001).6 Studies based on US national data also found
Table 2. Characteristics of Cases Enrolled in the North Carolina Stroke Care Collaborative, 2005–2010, by PSC Certification
Status
PSC Preparing for Certification Non-PSC P Value
N 14 885 6974 7795
Age, mean (SD) 66.8 (15.0) 69.4 (14.4) 70.7 (14.0) <0.01
Male, n (%) 7267 (48.8) 3339 (47.9) 3536 (45.4) <0.01
Nonwhite, n (%) 5223 (35.1) 1301 (18.7) 2025 (26.0) <0.01
Hispanic, n (%) 193 (1.4) 74 (1.1) 84 (1.1) 0.13
Health insurance, n (%)
Medicare 8343 (56.1) 4757 (68.2) 5423 (69.6) <0.01
Other 9677 (65.0) 4110 (58.9) 5235 (67.2) <0.01
None 1729 (11.6) 491 (7.0) 639 (8.2) <0.01
Stroke type, n (%)*
Ischemic 7049 (47.4) 2952 (42.3) 1933 (24.8) <0.01
Hemorrhagic 2942 (19.8) 817 (11.7) 628 (8.1) <0.01
Transient ischemic attack 3391 (22.8) 1477 (21.2) 2163 (27.8) <0.01
Not otherwise specified 1936 (13.0) 1945 (27.9) 3433 (44.0) <0.01
PSC indicates primary stroke center.
*Categories not mutually exclusive.
Table 3. Percentage of Cases in Compliance with Joint Commission Performance Measures, North Carolina Stroke Care
Collaborative, 2005–2010, by PSC Certification Status
Performance Measures PSC (n=15 405) Preparing for Certification (n=7281) Non-PSC (n=8314) v2 P Value
1. Received deep vein thrombosis prophylaxis 93.4 90.1 77.34 <0.01
2. Discharged on antithrombotic 98.7 97.8 95.1 <0.01
3. Patients with atrial fibrillation received anticoagulant 88.8 87.9 85.7 0.14
4 a. IV tPA received (among eligible ischemic strokes) 30.0 20.7 13.2 <0.01
b. IV tPA considered 70.7 70.3 31.1 <0.01
c. IV tPA received (among all ischemic strokes) 6.6 3.5 2.7 <0.01
5. Received antithrombotics within 48 hours 94.5 94.5 89.9 <0.01
6 a. Lipid profile measured during hospitalization 72.7 73.9 64.1 <0.01
b. If lipid profile measured, discharged on statin 97.0 96.3 94.9 <0.01
7. Screened for dysphasia 67.7 71.6 42.8 <0.01
8. Given stroke education 69.2 76.0 47.6 <0.01
9. Given smoking cessation counseling 87.6 94.0 91.2 <0.01
10. Considered for a rehabilitation plan 93.4 94.0 90.9 <0.01
Defect-free care 45.0 52.0 21.9 <0.01
Denominators vary based on exclusion/inclusion criteria. PSC indicates primary stroke center; IV tPA, intravenous tissue plasminogen activator.
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lower risk-adjusted mortality rates for PSC patients with both
ischemic and hemorrhagic stroke.18,19 Similarly, a Finnish
study reported lower 1-year stroke case fatality at certified
stroke centers.20 In contrast, an AHA Get With The Guidelines
Stroke study reported that while the hospitals’ geographical
region and academic status were independently associated
with risk-adjusted mortality and morbidity, PSC designation
was not.21 All of the hospitals, however, were participating in
a performance improvement program including all PSC PMs,
which may have reduced the potential effect of PSC
designation. A study evaluating the impact of the Get With
The Guidelines Stroke program reported that, independent of
secular trends, time of participation in the program was
associated with increased adherence to all stroke PMs.22 Still,
the greatest improvements were noted among hospitals that
received PSC certification. The similarity in percent change in
compliance with PMs among PSCs and those preparing for
certification suggests a continuum of quality improvement
and a benefit in the process of attaining certification.
Certain hospital characteristics such as bed size23 and
academic status14 have been associated with stroke care
quality, and hospitals with greater resources may have
provided high-quality care before the certification process
began.14 Although many key acute stroke care processes (eg,
stroke teams, stroke units, neurosurgery on staff, and
treatment protocols) may have been developed or improved
during certification, precertification differences in hospital
characteristics—including more physicians, specialists, equip-
Table 4. Odds Ratio and 95% CIs of Compliance with Joint Commission Performance Measures Among Cases Enrolled in the North
Carolina Stroke Care Collaborative, 2005–2010, by PSC Certification Status (Referent=non-PSC)
Performance Measures








1. Received deep vein
thrombosis prophylaxis
4.2 (3.7 to 4.7) 2.7 (2.3 to 3.1) 3.9 (3.4 to 4.4) 2.7 (2.4 to 3.2) 3.9 (2.6 to 5.9) 2.7 (1.3 to 5.6)
2. Discharged on
antithrombotic
4.0 (3.3 to 4.8) 2.3 (1.8 to 2.8) 4.1 (3.4 to 5.0) 2.2 (1.8 to 2.7) 2.5 (1.7 to 3.7) 1.6 (1.0 to 2.5)
3. Patients with atrial
fibrillation received
anticoagulant
1.3 (1.0 to 1.8) 1.2 (0.9 to 1.7) 1.3 (1.0 to 1.7) 1.2 (0.8 to 1.6) 1.2 (0.7 to 2.0) 1.2 (0.6 to 2.4)
4 a. IV tPA received
(among eligible
ischemic strokes)
2.8 (2.3 to 3.5) 1.7 (1.3 to 2.2) 2.8 (2.2 to 3.4) 1.7 (1.3 to 2.2) 2.4 (1.4 to 4.1) 1.5 (0.8 to 3.1)
b. IV tPA considered 5.4 (4.0 to 7.0) 5.2 (3.6 to 7.7) 5.4 (4.1 to 7.2) 5.3 (3.6 to 7.8) 4.8 (1.8 to 12.5) 2.9 (0.9 to 8.8)
c. IV tPA received
(among all ischemic
strokes)
2.6 (2.1 to 3.1) 1.3 (1.0 to 1.6) 2.6 (2.2 to 3.1) 1.3 (1.0 to 1.6) 2.2 (1.2 to 3.7) 1.2 (0.5 to 2.5)
5. Received antithrombotics
within 48 hours
1.9 (1.7 to 2.2) 1.9 (1.7 to 2.3) 1.9 (1.7 to 2.2) 2.0 (1.7 to 2.3) 2.5 (1.5 to 4.1) 3.1 (1.9 to 5.1)
6 a. Lipid profile measured
during hospitalization
1.5 (1.4 to 1.6) 1.6 (1.5 to 1.7) 1.4 (1.3 to 1.5) 1.5 (1.4 to 1.7) 1.1 (0.8 to 1.4) 1.2 (0.9 to 1.6)
b. If lipid profile measured,
discharged on statin
1.7 (1.3 to 2.4) 1.4 (1.0 to 2.0) 1.6 (1.2 to 2.2) 1.4 (1.0 to 1.9) 1.0 (0.6 to 1.7) 0.9 (0.4 to 2.3)
7. Screened for dysphasia 2.8 (2.6 to 3.0) 3.4 (3.1 to 3.6) 2.8 (2.7 to 3.0) 3.3 (3.1 to 3.6) 3.2 (2.1 to 5.0) 3.5 (2.5 to 4.9)
8. Given stroke education 2.5 (2.3 to 2.6) 3.5 (3.2 to 3.8) 2.5 (2.3 to 2.6) 3.3 (3.1 to 3.6) 4.0 (2.2 to 7.0) 3.9 (2.3 to 6.9)
9. Given smoking cessation
counseling
0.7 (0.6 to 0.9) 1.5 (1.1 to 2.0) 0.7 (0.6 to 0.9) 1.5 (1.1 to 1.9) 1.2 (0.5 to 2.9) 1.1 (0.5 to 2.6)
10. Considered for a
rehabilitation plan
1.4 (1.3 to 1.6) 1.6 (1.4 to 1.8) 1.7 (1.5 to 1.9) 1.8 (1.6 to 2.2) 1.5 (0.9 to 2.4) 1.6 (1.0 to 2.5)
Defect-free care 2.9 (2.8 to 3.1) 3.9 (3.6 to 4.1) 2.9 (2.7 to 3.1) 3.5 (3.3 to 3.8) 3.2 (2.1 to 4.7) 3.7 (2.5 to 5.5)
PSC indicates primary stroke center; IV tPA, intravenous tissue plasminogen activator.
*Unadjusted.
†Adjusted for age, sex, race, and stroke type.
‡Adjusted for age, sex, race, stroke type, and hospital bed size and accounting for clustering of patients within hospitals.
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ment, and other resources—may have facilitated their
implementation.24 Though PSCs tend to have different
characteristics than non-PSCs, PSCs do not have uniform
access, resources, capacity, and quality. Further, although
certain characteristics (eg, larger size, teaching status, and
urban setting) are associated with higher-quality care,
Table 5. Average Annual Absolute Percentage Change in Compliance with Joint Commission Performance Measures among Cases
Enrolled in the North Carolina Stroke Care Collaborative, 2005–2010, by PSC* Status (Referent=non-PSC)
Performance Measures PSC Preparing for Certification Non-PSC (Ref)
1. Received deep vein thrombosis prophylaxis 2.3 1.1† 5.1
2. Discharged on antithrombotic 0.1 0.2 0.1
3. Patients with atrial fibrillation received anticoagulant 3.4 9.9 7.7
4 a. IV tPA received (among eligible ischemic strokes) 1.6 3.0 1.1
b. IV tPA considered 9.9 18.4‡ 5.3
c. IV tPA received (among all ischemic strokes) <0.1† 0.9† 0.1
5. Received antithrombotics within 48 hours 2.3 4.5 4.3
6 a. Lipid profile measured during hospitalization 7.9 10.3‡ 6.3
b. If lipid profile measured, discharged on statin 1.1† 3.1† 2.2
7. Screened for dysphasia 3.9 6.6 3.7
8. Given stroke education 6.7 6.3 6.9
9. Given smoking cessation counseling 8.2‡ 3.2 2.1
10. Considered for a rehabilitation plan 1.9 2.5 2.0
Defect-free care 7.7† 8.1† 3.7
Denominators vary based on exclusion/inclusion criteria. PSC indicates primary stroke center; IV tPA, intravenous tissue plasminogen activator.
*Compliance measured in 3-month intervals, with the first 2 months of data excluded.
†F-test P<0.05.
‡F-test P<0.01.
Figure 2. Percentage of cases enrolled in the North Carolina Stroke Care Collaborative meeting Joint Commission performance measures,
2005–2010, by Primary Stroke Center certification status over time (months).
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high-quality care can still be provided in a dedicated center
that provides a coordinated system of care.23,25,26 Strategies
such as telemedicine to access stroke teams, ambulance
rerouting, and transfer agreements make process measures
attainable even by small rural hospitals.27 Multilevel modeling
to include the effect of hospital bed size was conducted to
address this concern.
Stroke patients treated at PSCs were generally younger,
male, and nonwhite and more likely to have hemorrhagic
strokes. PSCs treated a more severe patient population, as
suggested by the higher proportion of hemorrhagic stroke
cases.28 Stroke type may further affect care quality. Hemor-
rhagic stroke cases are less likely to receive smoking
cessation education and stroke education than were patients
with ischemic stroke or transient ischemic attack but are
more likely to receive care compliant with other PMs.29
Although few age differences have been reported,30 women
were less likely to receive IV tPA treatment and lipid testing,31
and black patients were more likely to have longer ED waiting
times32 and receive fewer evidence-based care processes
than were white or Hispanic patients.33
Participation in the NCSCC is voluntary, and participating
hospitals are more likely to have an interest in stroke quality
improvement. NCSCC hospitals, however, are similar to those
in other large stroke registries.13,34–37 Our study included
hospitals from all regions of NC and included a mix of
academic and nonacademic, rural and urban, and small and
large hospitals. Because the NCSCC requires no fee for
participation—in fact, it assists hospitals with the costs
associated with participation—barriers to participation are
low, and the NCSCC is more likely to include a diverse
population of hospitals. Approximately 62% of the nearly
27 000 stroke hospitalizations in NC each year are at
hospitals participating in the NCSCC.
Hospitals were encouraged to include all acute stroke
admissions; however, bias may occur if hospitals do not follow
instructions consistently.38 Periodic quality control studies
found that 83.7% of all acute strokes discharged from
participating hospitals were enrolled. This high case ascer-
tainment rate may be attributed to the use of both prospec-
tive and retrospective case capture methods and no
requirements to obtain written consent. Because the NCSCC
is a quality improvement registry and patient consent is not
required, the lack of consent precludes obtaining postdis-
charge outcomes data.
Conclusions
PSC certification is associated with an overall improvement
in the quality of stroke care in NC. Still, considerable room
for improvement remains, even among certified hospitals.
Additional organizational and policy changes and provider
and community education are needed for continued pro-
gress.14 Improved public knowledge about stroke symptoms
and the proper response is particularly critical if patients are
to be eligible for the most effective acute stroke care
options.
Nearly one-fifth of NC’s population resides in a county
without a PSC or a facility with telemedicine or a standing
transfer plan,14 underscoring the importance of identifying
facilities appropriate for PSC certification or, where unable,
using alternative quality improvement strategies.39 Assess-
ment of compliance with PMs allows for the monitoring of
changes and improvements in systems, operations, and
organization within hospitals. Continuous monitoring of care
measures in both PSCs and non-PSCs—particularly in a real-
time, prospective manner as done in the NCSCC—is critical if
quality improvement is to continue. Linking compliance levels
with outcomes will also be an important measure of the true
value of these system-level changes and must be addressed in
future studies.
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